MD, PhD

Associate Chief Physician, Researcher (Young Senior Professional), PhD Supervisor, and National-Level Young Talent.

Specialties: Clinical diagnosis and treatment of urological malignancies, with particular expertise in bladder cancer, prostate cancer, renal cancer, and other urological tumors; extensive experience in integrating clinical practice with AI-enabled precision diagnosis and treatment.

Academic Appointments: Secretary-General of the Intelligent Surgery Group of the Chinese Urological Association (CUA); Vice Chair of the Medical Artificial Intelligence Branch of the Guangdong Medical Association; Vice Chair of the Professional Committee on Artificial Intelligence and Medical Robotics of the Guangdong Medical Education Association; and Member of the Minimally Invasive and Robotic Surgery Group of the Urology Branch of the Chinese Medical Doctor Association (CUDA). Major Honors: The Second Prize of the National Science and Technology Progress Award and the First Prize of the Guangdong Provincial Science and Technology Progress Award.

Dr. Wu holds five granted invention patents and has led more than 10 research projects, including the National Science and Technology Major Project and General Programs of the National Natural Science Foundation of China, with total research funding exceeding RMB 16 million. More than 20 SCI-indexed papers have been published in leading international journals, including The Lancet Oncology, The Lancet Digital Health, Journal of the National Cancer Institute, and Clinical Cancer Research.